Taysha Gene Therapies
TSHA
#7359
Rank
$0.35 B
Marketcap
$1.72
Share price
0.00%
Change (1 day)
-23.89%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of December 2024 : $0.13 Billion USD

According to Taysha Gene Therapies's latest financial reports the company has $0.13 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.13 B-3.41%
2023-12-31$0.14 B63.79%
2022-12-31$87.88 M-41.06%
2021-12-31$0.14 B-40.66%
2020-12-31$0.25 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.25 B 84.10%๐Ÿ‡บ๐Ÿ‡ธ USA